Infectious Disease


Infectious Disease

Powering Epidemic Prevention

The ability to detect infectious disease biomarkers before the onset of an immune response, while a virus is most contagious and multiplying rapidly, is critical for controlling the spread of disease. Infectious disease is one of the hottest areas of research today and researchers continue to seek ways to detect and diagnose infections earlier and more accurately.

Simoa assays have the potential to have a significant impact in reducing the spread of the disease by making early stage detection more widely available.

Infectious Disease Assays
Available for Scientific Research

Latest Publications

Samples require no pretreatment, no special handling and no molecular laboratory measures against carryover contamination associated with amplification methods.

Latest News

Speaker:  Dan Sikkema, PhD, Vice President Biomarker Services, QuanterixModerator: Dr. Jayshan Carpen, Moderator, Nature Research
In this brief report, we tested cerebrospinal fluid (CSF) samples from 15 study participants for p24 antigen using a high sensitivity assay.